Press Release

Granules India Limited announced its unaudited financial results for Q1 FY27, reporting revenue from operations of INR 14,768 million, a 22% year‑on‑year increase. EBITDA rose to INR 3,389 million (+37% YoY) and profit after tax reached INR 1,800 million (+60% YoY). Net debt declined sharply to INR 1,012 million, reducing the net debt‑to‑EBITDA ratio to 0.07x, while ROCE improved to 18.0%. The company highlighted strong performance across its API, finished dosage, PFI and peptides CDMO segments and reiterated focus on regulatory excellence and portfolio transformation.